For example, SLC39A10 (ZIP10) is overexpressed in gastric, hepatic, and breast cancers, where it enhances tumor growth and metastasis via Zn2+-dependent signaling pathways such as PI3K/AKT and MAPK/ERK [51,52,53]. Here, AKT1 is linked to breast cancer.